All Articles by Author:
Laurisa Dohm
Dermal Cell News
Green Cocoon-Derived Sericin Reduces Cellular Damage Caused by Radiation in Human Keratinocytes
[Scientific Reports] Researchers investigated the effects of green cocoon-derived sericin on human keratinocytes using lactate dehydrogenase activity to indicate damage reduction.
Dermal Cell News
Collagen I Protects Human Keratinocytes HaCaT against UVB Injury via Restoring PINK1/Parkin-Mediated Mitophagy
[Archives Of Biochemistry And Biophysics] Cells grown on plates coated by molecular collagen I, but not fibrillar collagen I, acquired certain resistance against UVB damages, as shown by increased survival and reduced apoptosis.
Dermal Cell News
ANKRD1 Is a Mesenchymal-Specific Driver of Cancer-Associated Fibroblast Activation Bridging Androgen Receptor Loss to AP-1 Activation
[Nature Communications] Investigators identified ANKRD1 as a mesenchymal-specific transcriptional coregulator under direct androgen receptor negative control in human dermal fibroblasts and a key driver of cancer-associated fibroblasts conversion, independent of cellular senescence.
Dermal Cell News
Saracatinib Inhibits Necroptosis and Ameliorates Psoriatic Inflammation by Targeting MLKL
[Cell Death & Disease] In an imiquimod-induced psoriasis mouse model, saracatinib effectively blocked mixed lineage kinase domain-like protein (MLKL) phosphorylation and inflammatory responses in vivo.
Dermal Cell News
Differential Histone Acetylation and Super-Enhancer Regulation Underlie Melanoma Cell Dedifferentiation
[JCI Insight] Scientists identified ITGA3 gene as marked by a super-enhancer element in the Epgn3 invasive cells. Silencing of ITGA3 enhanced invasiveness in both in vitro and in vivo systems suggesting it as a negative regulator of invasion.
Dermal Cell News
Nuclear Mechanotransduction on Skin Stem Cell Fate Regulation
[Current Opinion In Cell Biology] Scientists focus on the key cytoplasmic and nuclear mechanosensitive structures that are critical for the mammalian skin development and homeostatic maintenance.
Popular
FDA Approves New Prostate Cancer Imaging Agent Gozellix®
[Telix Pharmaceuticals Limited] Telix announce that the US FDA has approved its New Drug Application for Gozellix®, Telix’s next-generation PSMA-PET imaging agent for prostate cancer.
Small-Molecule RNA Therapeutics to Target Prostate Cancer
[Cancer Cell] To understand whether targeting RNA structure using small molecules in the most lethal form of prostate cancer, castration-resistant prostate cancer, the authors used a clinical small molecule, zotatifin, that targeted the RNA helicase and translation factor eukaryotic initiation factor 4A.
Lipid-Metabolism-Focused CRISPR Screens Identify Enzymes of the Mevalonate Pathway As Essential for Prostate Cancer Growth
[Cell Reports] Researchers employed a CRISPR-Cas9 screen using a custom human lipid metabolism knockout library to identify essential genes for prostate cancer survival.